Novel genetic and epigenetic alterations in ... - Ous-research.no
Novel genetic and epigenetic alterations in ... - Ous-research.no
Novel genetic and epigenetic alterations in ... - Ous-research.no
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
An association between hypermethylation <strong>and</strong> lackof expression has previously been shown for allgenes analyzed <strong>in</strong> the present study.[8-10,18-21]Although multiple genes are methylated <strong>in</strong> a cancer,only some are functionally <strong>in</strong>volved <strong>in</strong>tumorigenesis,[22-24] whereas others with unk<strong>no</strong>wnfunctional contribution still may serve as goodbiomarkers from a diag<strong>no</strong>stic perspective.Figure 3. Methylation HeatMap. Hierarchical cluster<strong>in</strong>greveals that methylation of NR3C1 <strong>and</strong> RUNX3 are mostclosely related, followed by MLH1 <strong>and</strong> CRABP1.Methylation of MGMT <strong>and</strong> HOXA9 are most <strong>in</strong>dependentboth from each other <strong>and</strong> from rest of the set. The genesare presented <strong>in</strong> columns, while the samples arepresented <strong>in</strong> rows. Black, unmethylated; red, methylated;<strong>and</strong> grey, miss<strong>in</strong>g values.than the rema<strong>in</strong><strong>in</strong>g ade<strong>no</strong>mas (mean = 10 mm; P =0.013). In carc<strong>in</strong>omas, widespread methylation wasseen more frequently <strong>in</strong> MSI (16/27; 59%) than <strong>in</strong>MSS (3/25; 12%) samples (P = 0.001). All sixteenMSI samples with widespread methylation showedsimilar molecular profiles when DNA methylationstatus, TP53-, KRAS-, <strong>and</strong> BRAF-mutation statuswere considered, <strong>in</strong> l<strong>in</strong>e with a CIMP positivephe<strong>no</strong>type (Figure 4). The three MSS samples withwidespread methylation <strong>in</strong>cluded one tumor withTP53 mutation, one with both TP53 <strong>and</strong> KRASmutation <strong>and</strong> one with BRAF mutation.The distribution of the carc<strong>in</strong>omas comb<strong>in</strong>ed with<strong>in</strong>formation regard<strong>in</strong>g sex, age, MSI-status, <strong>and</strong>widespread methylation is illustrated <strong>in</strong> Figure 5.From the figure we see that widespread methylationis associated with proximal tumors derived fromelderly women.DiscussionWe demonstrate <strong>in</strong> the present study aberrantpromoter methylation of several genes, at variablefrequencies, <strong>in</strong> the stepwise development ofcolorectal tumors.Compar<strong>in</strong>g methylation profiles of <strong>no</strong>rmalmucosa, ade<strong>no</strong>mas <strong>and</strong> carc<strong>in</strong>omas of the largebowelThe identified methylation profiles of <strong>no</strong>rmalcolorectal tissues, ade<strong>no</strong>mas, <strong>and</strong> carc<strong>in</strong>omasdemonstrated a stepwise <strong>in</strong>crease <strong>in</strong> CpG isl<strong>and</strong>promoter methylation towards malignancy,<strong>in</strong>dicat<strong>in</strong>g that their <strong>in</strong>activation plays a role <strong>in</strong> theprogression of the tumor. This was evident both forwidespread methylation <strong>and</strong> at the s<strong>in</strong>gle gene level(<strong>in</strong>creas<strong>in</strong>g frequencies of methylation from benignto malignant stages) with the exception of HOXA9,MAL, <strong>and</strong> MGMT. The lack of <strong>in</strong>crease <strong>in</strong>methylation frequencies between <strong>no</strong>n-malignantade<strong>no</strong>mas <strong>and</strong> carc<strong>in</strong>omas for these three genesmay suggest that they are more important <strong>in</strong> the<strong>in</strong>itiation of cancer, rather than <strong>in</strong> progression.These genes <strong>in</strong> addition to ADAMTS1 were alsohypermethylated <strong>in</strong> comparable frequencies amongMSS <strong>and</strong> MSI carc<strong>in</strong>omas. These observations, <strong>and</strong>the fact that the separation of the MSI- <strong>and</strong> MSSpathwayis thought to occur early <strong>in</strong> colorectaltumorigenesis suggest that <strong>alterations</strong> of the fourgenes represent early events. ADAMTS1 is believedto be an <strong>in</strong>hibitor of both angiogenesis <strong>and</strong>endothelial proliferation,[25] features commonlyactivated <strong>in</strong> cancer, as a tumor must turn onangiogenesis <strong>in</strong> order to grow larger than 1-2mm 3 [26]. Members of the HOX gene family areshown to be commonly altered <strong>in</strong> several cancers,<strong>and</strong> to the best of our k<strong>no</strong>wledge, this is the firstreport of HOXA9 methylation <strong>in</strong> colorectalneoplasms. HOXA9 methylation has received<strong>in</strong>creas<strong>in</strong>g <strong>in</strong>terest <strong>in</strong> recent time as it is <strong>in</strong>cluded <strong>in</strong>the HOXA-cluster which harbors methylation over alarger area than just a s<strong>in</strong>gle promoter, <strong>in</strong>dicat<strong>in</strong>gthat methylation may mimic <strong>genetic</strong> micro-deletions<strong>and</strong> turn off a cluster of genes rather than just oneat the time, i.e. yet a<strong>no</strong>ther example of long rangeepi<strong>genetic</strong> silenc<strong>in</strong>g.[27-29]. MAL is <strong>in</strong>volved <strong>in</strong> T-cell differentiation, especially <strong>in</strong> the late or<strong>in</strong>termediate stages.[30] It is also <strong>in</strong>volved <strong>in</strong>Figure 4. Genetic <strong>and</strong> epi<strong>genetic</strong> changes <strong>in</strong> colorectal carc<strong>in</strong>omas with k<strong>no</strong>wn microsatellite statusThe results are visualized accord<strong>in</strong>g to <strong>genetic</strong> (top part of the figure) <strong>and</strong> epi<strong>genetic</strong> changes (lower part of the figure). Theresults are organized accord<strong>in</strong>g to MSI, followed by BRAF-, KRAS-, TP53- <strong>and</strong> methylation-status of the MSI associated genes.5